Terlipressin
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Terlipressin and local guidelines before prescribing.
Vasopressin analogue
Mechanism
Vasopressin analogue acting on V1 receptors.
Uses
Variceal haemorrhage, hepatorenal syndrome.
Dosing
- Terlipressin Variceal bleed | e.g. 2 mg IV every 4–6 hours (local protocol), reduced after haemostasis; usually 2–5 days. Caution in ischaemic heart disease; watch sodium.
Gastroenterology: Gastroenterology Emergencies (Complete) - Human albumin 20% | SBP: 1.5 g/kg at diagnosis and 1 g/kg on day 3. Paracentesis: about 8 g per litre drained if more than 5 L. HRS: with terlipressin.
Gastroenterology: Gastroenterology Emergencies (Complete) - Upper GI bleed | ABCDE, two large-bore cannulas, crossmatch, Glasgow–Blatchford score, transfuse (restrictive Hb 70 g/L, 80 g/L in cardiac disease), stop anticoagulants and reverse, terlipressin and antibiotics if variceal, endoscopy within 24 hours (immediately after resuscitation if unstable)
OSCEs II: Practical procedures, prescribing and acute care stations
Side effects
Ischaemic events, bradycardia, hyponatraemia, respiratory failure.
Interactions
Other vasoconstrictors.
Contraindications and cautions
Coronary and peripheral ischaemia
Monitoring
Sodium, ECG, urine output
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Caution in renal impairment
Overdose and reversal
Supportive
Special advice
Contraindicated with hypoxia or fluid overload.
More from the textbook: uses, cautions and other points
- V1 receptors on blood vessels → vasoconstriction (vasopressin and terlipressin in shock and variceal bleeding).
Endocrine: Anatomy Physiology and Pharmacology - Mechanism - scarred liver resists flow, plus increased blood flow into the portal system from splanchnic vasodilatation (nitric oxide) - so treatment both lowers resistance and reduces inflow (non-selective beta-blockers reduce cardiac output via beta-1 and allow splanchnic vasoconstriction via beta-2 blockade; terlipressin constricts …
Gastroenterology: Anatomy Physiology Pharmacology - Hepatorenal syndrome - extreme kidney vasoconstriction from the same process → AKI without kidney damage; treated with terlipressin and albumin .
Gastroenterology: Anatomy Physiology Pharmacology - Hepatorenal syndrome - with terlipressin.
Gastroenterology: Anatomy Physiology Pharmacology - Terlipressin | Variceal bleed and hepatorenal syndrome; ischaemia, hyponatraemia, respiratory failure (MHRA).
Gastroenterology: Anatomy Physiology Pharmacology - Terlipressin and IV antibiotics before endoscopy; urgent endoscopy after resuscitation with band ligation ; Pabrinex.
Gastroenterology: Anatomy Physiology Pharmacology - Variceal bleed: terlipressin, antibiotics, restrictive transfusion, banding.
Gastroenterology: Anatomy Physiology Pharmacology - MHRA Drug Safety Updates: PPIs, metoclopramide, domperidone, ondansetron, loperamide, hyoscine butylbromide injection, JAK inhibitors, terlipressin, clozapine
Gastroenterology: Anatomy Physiology Pharmacology
Where it is discussed in the book
- Endocrine: Anatomy Physiology and Pharmacology (1 mention)
- Gastroenterology: Anatomy Physiology Pharmacology (7 mentions)
- Gastroenterology: Gastroenterology Emergencies (Complete) (5 mentions)
- Gastroenterology: Cirrhosis and Transplantation (1 mention)
- Renal: Emergencies (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (1 mention)
- Acute Medicine: Shock, sepsis and critical illness (1 mention)
- Acute Medicine: The acute medical take (3 mentions)
- Critical care: common problems, ethics and recovery (1 mention)
- 0210 (1 mention)
- OSCEs II: Practical procedures, prescribing and acute care stations (1 mention)
- 0241-thoracic-wall-and-diaphragm (1 mention)